These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23792179)

  • 1. The influence of comorbid personality disorder on the effects of behavioural activation vs. antidepressant medication for major depressive disorder: results from a randomized trial in Iran.
    Moradveisi L; Huibers MJ; Renner F; Arasteh M; Arntz A
    Behav Res Ther; 2013 Aug; 51(8):499-506. PubMed ID: 23792179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of patients' preference/attitude towards psychotherapy and antidepressant medication on the treatment of major depressive disorder.
    Moradveisi L; Huibers M; Renner F; Arntz A
    J Behav Ther Exp Psychiatry; 2014 Mar; 45(1):170-7. PubMed ID: 24172145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural activation v. antidepressant medication for treating depression in Iran: randomised trial.
    Moradveisi L; Huibers MJ; Renner F; Arasteh M; Arntz A
    Br J Psychiatry; 2013 Mar; 202(3):204-11. PubMed ID: 23391727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of patients' attributions of the immediate effects of treatment of depression on long-term effectiveness of behavioural activation and antidepressant medication.
    Moradveisi L; Huibers MJ; Arntz A
    Behav Res Ther; 2015 Jun; 69():83-92. PubMed ID: 25898343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive personality and treatment outcome in major depressive disorder.
    Ryder AG; Quilty LC; Vachon DD; Bagby RM
    J Pers Disord; 2010 Jun; 24(3):392-404. PubMed ID: 20545502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunctional cognitions of depressive inpatients and their relationship with treatment outcome.
    Köhler S; Unger T; Hoffmann S; Mackert A; Ross B; Fydrich T
    Compr Psychiatry; 2015 Apr; 58():50-6. PubMed ID: 25639696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does personality disorder co-morbidity impact treatment outcome for patients with major depression? A multi-level analysis.
    De Bolle M; De Fruyt F; Quilty LC; Rolland JP; Decuyper M; Bagby RM
    J Pers Disord; 2011 Feb; 25(1):1-15. PubMed ID: 21309619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of older adults with co-morbid personality disorder and depression: a dialectical behavior therapy approach.
    Lynch TR; Cheavens JS; Cukrowicz KC; Thorp SR; Bronner L; Beyer J
    Int J Geriatr Psychiatry; 2007 Feb; 22(2):131-43. PubMed ID: 17096462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problem-solving ability and comorbid personality disorders in depressed outpatients.
    Harley R; Petersen T; Scalia M; Papakostas GI; Farabaugh A; Fava M
    Depress Anxiety; 2006; 23(8):496-501. PubMed ID: 16845662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study results from a randomized controlled trial of cognitive behavioural guided self-help in patients with partially remitted depressive disorder.
    Schlögelhofer M; Willinger U; Wiesegger G; Eder H; Priesch M; Itzlinger U; Bailer U; Schosser A; Leisch F; Aschauer H
    Psychol Psychother; 2014 Jun; 87(2):178-90. PubMed ID: 23681925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
    Barber JP; Barrett MS; Gallop R; Rynn MA; Rickels K
    J Clin Psychiatry; 2012 Jan; 73(1):66-73. PubMed ID: 22152401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of personality disorder pathology on the effectiveness of Cognitive Therapy and Interpersonal Psychotherapy for Major Depressive Disorder.
    van Bronswijk SC; Lemmens LHJM; Viechtbauer W; Huibers MJH; Arntz A; Peeters FPML
    J Affect Disord; 2018 Jan; 225():530-538. PubMed ID: 28866297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study.
    Edinger JD; Manber R; Buysse DJ; Krystal AD; Thase ME; Gehrman P; Fairholme CP; Luther J; Wisniewski S
    J Clin Sleep Med; 2017 Feb; 13(2):205-213. PubMed ID: 27784414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major depression and its response to sertraline in primary care vs. psychiatric office practice patients. Results of an open-label trial in Argentina.
    Lyketsos CG; Taragano F; Treisman GJ; Paz J
    Psychosomatics; 1999; 40(1):70-5. PubMed ID: 9989124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of depressive disorder and comorbid personality pathology: combined therapy versus pharmacotherapy].
    Kool S; Schoevers R; Duijsens IJ; Peen J; van Aalst G; de Jonghe F; Dekker J
    Tijdschr Psychiatr; 2007; 49(6):361-72. PubMed ID: 17611937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of comorbid personality disorder and neuroticism on treatment outcome in first episode depression.
    Bock C; Bukh JD; Vinberg M; Gether U; Kessing LV
    Psychopathology; 2010; 43(3):197-204. PubMed ID: 20375542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment.
    Saveanu R; Etkin A; Duchemin AM; Goldstein-Piekarski A; Gyurak A; Debattista C; Schatzberg AF; Sood S; Day CV; Palmer DM; Rekshan WR; Gordon E; Rush AJ; Williams LM
    J Psychiatr Res; 2015 Feb; 61():1-12. PubMed ID: 25586212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive lithium treatment in the prevention of suicidal behavior in patients with depression and comorbid personality disorders.
    Rombold F; Lauterbach E; Felber W; Mueller-Oerlinghausen B; Ahrens B; Bronisch T; Kilb B; Lewitzka U; Richter K; Broocks A; Heuser I; Hohagen F; Quante A
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):300-3. PubMed ID: 24994476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CPAP treatment on residual depressive symptoms in patients with major depression and coexisting sleep apnea: Contribution of daytime sleepiness to residual depressive symptoms.
    Habukawa M; Uchimura N; Kakuma T; Yamamoto K; Ogi K; Hiejima H; Tomimatsu K; Matsuyama S
    Sleep Med; 2010 Jun; 11(6):552-7. PubMed ID: 20488748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.